DSCR1 (ADAPT78) lethality: evidence for a protective effect of trisomy 21 genes?

Kerri S Kluetzman1, Ana V Perez, Dana R Crawford

  • 1Transgenic Facility, The Genomics Institute, Wadsworth Center, Troy, NY 12180, USA.

Insights

DSCR1 (Down syndrome candidate region 1) gene expression in transgenic mice caused embryonic lethality. This suggests DSCR1 may confer lethality, while other Down syndrome genes might suppress it.

Area of Science:

  • Genetics
  • Developmental Biology
  • Down Syndrome Research

Background:

  • Growing evidence suggests a role for DSCR1 (Down syndrome candidate region 1) in Down syndrome.
  • Previous studies indicated DSCR1 overexpression in Down syndrome mouse models, which survived to term.

Purpose of the Study:

  • To investigate the role of DSCR1 in Down syndrome by generating DSCR1 transgenic mice.
  • To determine the effect of DSCR1 expression on embryonic development and survival.

Main Methods:

  • Generation of DSCR1 transgenic mice on a C57Bl/6 background.
  • Monitoring of transgene presence and mRNA expression during embryonic development.
  • Observation of embryonic lethality and survival rates.

Main Results:

  • Transgenic mice exhibited a high incidence of embryonic lethality.
  • DSCR1 transgene and mRNA were detected in lethal embryos up to day 9.5.
  • Rare surviving transgenics showed no DSCR1 mRNA expression, indicating expression is linked to lethality.
  • This lethal phenotype contrasts with existing Down syndrome mouse models.

Conclusions:

  • DSCR1 expression alone appears to cause embryonic lethality in mice.
  • This finding challenges previous observations in Down syndrome models.
  • A hypothesis is proposed where some trisomy genes, including DSCR1, may confer lethality, while others suppress it, explaining the discrepancy.